Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Return of mice to home cage evokes significant rise in dopamine release, shows study

Return of mice to home cage evokes significant rise in dopamine release, shows study

Biologists investigate how molecular chaperones dissolve protein aggregates linked to Parkinson's

Biologists investigate how molecular chaperones dissolve protein aggregates linked to Parkinson's

MU researcher develops procedures for defining the preclinical stages of Alzheimer's disease

MU researcher develops procedures for defining the preclinical stages of Alzheimer's disease

Severe obstructive sleep apnea linked to increased risk of dementia

Severe obstructive sleep apnea linked to increased risk of dementia

Study: Retired professional athletes may not suffer more severe cognitive impairment than others

Study: Retired professional athletes may not suffer more severe cognitive impairment than others

Study may lead to new therapies that accelerate removal of cellular debris from the brain

Study may lead to new therapies that accelerate removal of cellular debris from the brain

“Molecular volume knob” in the brain helps with learning, memory

“Molecular volume knob” in the brain helps with learning, memory

Psychological factors are linked to incorrect fall risk perception in dementia patients

Psychological factors are linked to incorrect fall risk perception in dementia patients

Study focuses on efficacy of cognitive rehabilitation across a range of neurological conditions

Study focuses on efficacy of cognitive rehabilitation across a range of neurological conditions

Targeting TAAR5 can provide a new treatment opportunity for neurodegenerative disorders

Targeting TAAR5 can provide a new treatment opportunity for neurodegenerative disorders

Nanoparticles could treat neurodegenerative diseases, shows study

Nanoparticles could treat neurodegenerative diseases, shows study

Researchers investigate natural compound for treating amnestic Mild Cognitive Impairment

Researchers investigate natural compound for treating amnestic Mild Cognitive Impairment

Research explores links between Alzheimer's and Parkinson′s to COVID-19

Research explores links between Alzheimer's and Parkinson′s to COVID-19

Virginia Tech professor expands caregiving study during COVID-19 pandemic

Virginia Tech professor expands caregiving study during COVID-19 pandemic

Study shows oxidant hydrogen peroxide can actually slow down cell ageing

Study shows oxidant hydrogen peroxide can actually slow down cell ageing

Researchers analyze metrics of cognitive decline in diverse Latinx populations

Researchers analyze metrics of cognitive decline in diverse Latinx populations

Study: Genetically edited form of herpes simplex virus outperforms leading vaccine candidate

Study: Genetically edited form of herpes simplex virus outperforms leading vaccine candidate

Researchers gain novel insights into the role of autophagy in neurons

Researchers gain novel insights into the role of autophagy in neurons

HKUST researchers identify new therapeutic targets for Alzheimer's disease

HKUST researchers identify new therapeutic targets for Alzheimer's disease

NIH awards grant totaling $19.5M for Down syndrome research project

NIH awards grant totaling $19.5M for Down syndrome research project

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.